CUIDAme. Metabolismo y nutrición
University of Würzburg
Wurzburgo, AlemaniaPublicaciones en colaboración con investigadores/as de University of Würzburg (9)
2013
2012
-
Effectiveness of teriparatide in postmenopausal women with osteoporosis and glucocorticoid use: 3-Year results from the EFOS study
Journal of Rheumatology, Vol. 39, Núm. 3, pp. 600-609
-
Effectiveness of teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS)
Calcified Tissue International, Vol. 90, Núm. 5, pp. 373-383
-
Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study
European Journal of Endocrinology, Vol. 166, Núm. 1, pp. 87-97
2011
-
Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS)
Osteoporosis International, Vol. 22, Núm. 10, pp. 2709-2719
2009
-
Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS)
Calcified Tissue International, Vol. 85, Núm. 6, pp. 484-493
2008
-
Characterization of patients in the European Forsteo Observational Study (EFOS): Postmenopausal women entering teriparatide treatment in a community setting
Current Medical Research and Opinion, Vol. 24, Núm. 2, pp. 377-384
-
Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: The Observational Study of Severe Osteoporosis (OSSO)
Osteoporosis International, Vol. 19, Núm. 4, pp. 493-501